The effect of ketorolac compared to pethidine in pain management after surgery

The effect of ketorolac compared to pethidine in pain management following pelvic reconstructive surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220620055225N4

Enrollment

Registered

2025-09-07

Start date

2025-09-23

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic and perineal pain. Pelvic and perineal pain

Interventions

Intervention 1: Intervention group: After surgery, the patient received IV Ketorolac 30 mg twice daily and Apotel as needed (PRN), up to a maximum of 4 doses. Intervention 2: Control group: After sur

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Indications for anterior perineal reconstruction surgery Willingness to participate in the study

Exclusion criteria

Exclusion criteria: Allergy to study drugs History of chronic pelvic pain Having liver, kidney, or heart diseases

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: Once, morning after the surgery. Method of measurement: Visual analog scale.	—

Secondary

Measure	Time frame
Amount of pethidine needed. Timepoint: Once, morning after the surgery. Method of measurement: pethidine dosage.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKhadijeh Adabi

Tehran University of Medical Sciences

kh_adabi@sina.tums.ac.ir+98 21 8894 8217

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026